Management of Malignant Pericardial Effusion with Instillation of Mitomycin C in Non-small Cell Lung Cancer

Kaira, Kyoichi; Takise, Atsushi; Kobayashi, Go; Utsugi, Mitsuyoshi; Horie, Takeo; Mori, Takanori; Imai, Hisao; Inazawa, Masahito; Mori, Masatomo

doi:10.1093/jjco/hyi019

Cited by 23 publications

(19 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… 14 Talcage involves instilling a sclerosing agent with the intention of scarring the pericardium to the epicardium. Multiple agents have been studied including Tetracycline and Doxycycline, 15 Minocycline, 16 Thiotepa, 17 , 18 platinum derivatives, 19 – 21 Mitoxantrone, 22 Mitomycin C, 23 and Bleomycin. 24 – 26 Success rates (expressed as no reaccumulation at 30 days) range from 70% to 90%.…”

Section: Introductionmentioning

confidence: 99%

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion

et al. 2016

View full text Add to dashboard Cite

Malignant pericardial effusion (MPE) is a serious complication of several cancers. The most commonly involved solid tumors are lung and breast cancer. MPE can give rise to the clinical picture of cardiac tamponade, a life threatening condition that needs immediate drainage. While simple pericardiocentesis allows resolution of the symptoms, MPE frequently relapses unless further procedures are performed. Prolonged drainage, talcage with antineoplastic agents, or surgical creation of a pleuro-pericardial window are the most commonly suggested ones. They all result in MPE resolution and high rates of long-term control. Patients suitable for further systemic treatments can have a good prognosis irrespective of the pericardial site of disease. We prospectively enrolled patients with cardiac tamponade treated with prolonged drainage associated with Bleomycin administration.Twenty-two consecutive patients with MPE and associated signs of hemodynamical compromise underwent prolonged drainage and subsequent Bleomycin administration. After injection of 100 mg lidocaine hydrochloride, 10 mg Bleomycin was injected into the pericardial space. The catheter was clumped for 48 h and then reopened. Removal was performed when the drainage volume was <25 mL daily.Twelve patients (54%) achieved complete response and 9 (41%) a partial response. Only 1 (5%) had a treatment failure and underwent a successful surgical procedure. Acute toxicity was of a low degree and occurred in 7 patients (32%). It consisted mainly in thoracic pain and supraventricular arrhythmia. The 1-year pericardial effusion progression-free survival rate was 74.0% (95% confidence interval [CI]: 51.0–97.3). At a median follow-up of 75 months, a pericardial progression was detected in 4 patients (18%). One- and two-year overall survival rates were 33.9% (95% CI: 13.6–54.2) and 14.5% (95% CI: 0.0–29.5), respectively, with lung cancer patients having a shorter survival than breast cancer patients. The worst prognosis, however, was shown in patients not suitable for systemic treatments, irrespective of the site of the primary tumor.Prolonged drainage and intrapericardial Bleomycin is a safe and effective treatment, which should be considered as first choice at least in patients suitable for active systemic treatment.

show abstract

Section: Introductionmentioning

confidence: 99%

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Unlike other malignant effusions, those caused by NSCLC have low sensitivity to chemo-and radiotherapy [84][85][86]; therefore these patients are candidates for palliative therapy. In a similar way, NSCLC is the most frequent cause of malignant pericardial effusion, which has a grim prognosis too [87][88][89].…”

Section: Pl3mentioning

confidence: 95%

Bronchology – A Well Branched Tree

Olteanu¹,

Streba²,

Oprea³

et al. 2013

Endoscopy

View full text Add to dashboard Cite

“…Agents including bleomycin, carboplatin, cisplatin, and mitomycin-C have been used for this purpose (Kaira et al, 2005;Maisch, Ristic, and Pankuweit, 2010;Maruyama et al, 2007;Moriya et al, 2000). Systemic chemotherapy may be helpful.…”

Section: Managementmentioning

confidence: 99%

Oncologic emergencies in critical care

Barbarotta

2015

Critical Care Nursing

View full text Add to dashboard Cite

show abstract

Management of Malignant Pericardial Effusion with Instillation of Mitomycin C in Non-small Cell Lung Cancer

Abstract: Intrapericardial instillation of 2 mg of mitomycin C was feasible and demonstrated a promising response against malignant pericardial effusion resulting from non-small cell lung cancer.

Cited by 23 publications

References 11 publications

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion

Bronchology – A Well Branched Tree

Oncologic emergencies in critical care

Contact Info

Product

Resources

About